Ask AI
ProCE Banner Series

Best Practices for Managing Long-Term Toxicities From CAR T-Cell Therapy: Educational Insights and Resources for Oncology Nurses in the Community

Improve your understanding of long-term toxicities associated with CAR T-cell therapy based on the latest evidence and expert recommendations to improve patient care and optimize safety through an expert-authored ClinicalThought commentary, accredited on-demand webcast, accompanying downloadable slides, and downloadable pocket guide.

  ANCC with Pharmacotherapy Credit
Who Should Attend

This activity has been designed to meet the educational needs of community oncology nurses, nurse practitioners, and other healthcare professionals who care for patients treated with CAR T-cell therapies.

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of community oncology nurses, nurse practitioners, and other healthcare professionals in educating and caring for patients treated with CAR T-cell therapies.

Target Audience
This activity has been designed to meet the educational needs of community oncology nurses, nurse practitioners, and other healthcare professionals who care for patients treated with CAR T-cell therapies.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify patients at increased risk for long-term toxicities related to CAR T-cell therapy
  • Counsel patients and caregivers on the onset, symptoms, and clinical manifestations of short-term vs long-term toxicities related to CAR T-cell therapy
  • Implement strategies to monitor for and manage long-term toxicities in patients treated with CAR T-cell therapy based on the latest guidelines, expert recommendations, and evidence
  • Develop plans for transitioning care from the CAR T-cell treating center to community practice that optimize the patient’s long-term safety and quality of life
  •  

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit. 

ILNA Recertification Points

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:

  • Care Continuum (OCN, CBCN, CPHON, AOCNP) - 1.0*
  • Care of the Pediatric Hematology and Oncology Patient (CPHON) - 1.0*
  • Early Post-Transplant Management and Education (BMTCN) - 1.0*
  • Foundations of Transplant (BMTCN) - 1.0*
  • Health Maintenance (CPHON) - 1.0*
  • Late Post-Transplant Management and Education (BMTCN) - 1.0*
  • Oncologic Emergencies (OCN, CPHON, AOCNP) - 1.0*
  • Oncology Nursing Practice (OCN) - 1.0*
  • Pediatric Hematology and Oncology Nursing Practice (CPHON) - 1.0*
  • Psychosocial Dimensions of Care (AOCNP, CPHON, OCN, CBCN) - 1.0*
  • Quality of Life (BMTCN) - 1.0*
  • Symptom Management, Palliative Care, Supportive Care (OCN, CPHON, AOCNP) - 1.0*
  • Treatment (OCN, CBCN, AOCNP, CPHON) - 1.0*

Total Points: 1.0*

*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area.  The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) awarded from this course.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by educational grants from Bristol-Myers Squibb and Johnson & Johnson.

Bristol Myers Squibb

Johnson & Johnson

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191